What is the Impact Factor of Antiviral Chemistry and Chemotherapy?

The journal Antiviral Chemistry and Chemotherapy is indexed in Web of Science (SCIE, quartile Q1) with official metrics continually updated on ImpaQ.

Is Antiviral Chemistry and Chemotherapy indexed in Web of Science or Scopus?

Yes, Antiviral Chemistry and Chemotherapy is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.230 (Q4) and an H-index of 62.

Who publishes Antiviral Chemistry and Chemotherapy and what is the Article Processing Charge (APC)?

Antiviral Chemistry and Chemotherapy is published by SAGE. The estimated Article Processing Charge (APC) is approximately $2,882 USD, subject to institutional waivers and corresponding author affiliations.

WoS SCIE Q1Scopus Q4SCImago #20,234Diamond OA

Antiviral Chemistry and Chemotherapy

Identifier (ISSN):0956-3202(Print)/2040-2066(Online)

•

Publisher:SAGE

Clarivate JCR Index Advisory: Not Indexed in Latest JCR

Official Website Submission Portal Compare

Clarivate Impact Factor (IF 2024)

N/A

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

Impact Factor Trend

Clarivate IF trend for Antiviral Chemistry and Chemotherapy

WoS Q1

Annual Impact Factor Metric

Current (2023):0

Scopus SJR & RankScopus Q4

0.23

#20,234

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

62 papers with at least that number of citations each

WoS: SCIE / JCRQ1

Self-Citation RateN/A

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessDiamond OA

0articles/year

0% Gold OA•0% Original Research

Aims & Scope

Antiviral Chemistry & Chemotherapy publishes the results of original research concerned with the biochemistry, mode of action, chemistry, pharmacology and virology of antiviral compounds. Manuscripts dealing with molecular biology, animal models and vaccines are welcome. The journal also publishes reviews, pointers, short communications and correspondence.

Topics Covered (Recognized by AI)

Biology98.3%Genetics94.6%Medicine92.4%Chemistry89.3%Biochemistry86%Virology84.3%Immunology82.8%Virus77.6%Gene51.7%Organic chemistry46.8%Family medicine45.9%Human immunodeficiency virus (HIV)45.8%In vitro45.3%Stereochemistry38.5%Internal medicine37.3%Viral disease34.6%Physics31.3%Pharmacology31%Cell culture30.2%Nuclear magnetic resonance27.5%Enzyme24.4%RNA23.2%Nucleoside20.6%

Primary Research Areas

Pharmacology Toxicology and Pharmaceutics

Official Website NLM PubMed Catalog SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR

No WoS category details available for this journal.

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2023Latest

IF0

Articles / Year2

Total Citations11

2022

IF—

Articles / Year6

Total Citations23

2021

IF—

Articles / Year9

Total Citations42

2020

IF—

Articles / Year15

Total Citations266

2019

IF—

Articles / Year6

Total Citations212

Year	Impact Factor	Articles / Year	Total Citations
2023	0	2	11
2022	—	6	23
2021	—	9	42
2020	—	15	266
2019	—	6	212
2018	—	19	735
2017	—	11	205
2015	—	20	293
2014	—	2	1
2013	—	15	382
2012	—	16	434
2011	—	31	749

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #20,234Scopus Q4SCImago Profile

Scopus Coverage:1990-2015, 2017-2023

•

Scopus Broad Areas:Immunology and MicrobiologyMedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q4

0.23

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q4

Citations / Doc (2 years)

1.50

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$2,882 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations7

3-Year Documents8

Citable Documents8

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate0.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Drug DiscoveryQ4

Medicine (miscellaneous)Q4

PharmacologyQ4

VirologyQ4

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

Updating

Minor Category (Specific Field):

Updating

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Antiviral Chemistry and Chemotherapy (ISSN: 0956-3202) is a peer-reviewed international scholarly journal in the field of Pharmacology, published by SAGE in United Kingdom. The periodical holds tracked under Web of Science (SCIE) in quartile Q1, a Scopus SJR indicator of 0.230 (Q4), an H-index of 62.

The journal enforces rigorous peer evaluation with an annual output of approximately 0 scientific articles. In terms of accessibility and author fees, it operates under the Diamond OA model with an estimated APC of $2,882 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.